ADPT

NASDAQ · Life Sciences Tools & Services

Adaptive Biotechnologies

Mid-Cap Stocks Healthcare Stocks

$13.58

+0.08 (+0.59%)

As of Mar 22, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +534.8% upside

Low Target $68.90

Average Target $86.20

High Target $131.13

Current Price $13.58

Current
$13.58

Target
$86.20

$68.90 $86.20 avg $131.13

Scenario Analysis

Bear Case

$68.90

407.4%

Low target

Base Case

$86.20

+534.8%

Avg target

Bull Case

$131.13

+865.6%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$20.76

-34.6% from high

52-Week Low

$6.26

+117.1% from low

50-Day SMA

$16.81

-19.2% vs SMA

200-Day SMA

$13.88

-2.2% vs SMA

RSI (14)

24.2

Oversold

Target vs 52W High

$86.20

+315.2% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	33	88%	$369.21	-24.8%
DHR Danaher Corp	Strong Buy	30	87%	$158.11	-15.5%
A Agilent Technologies Inc	Buy	29	72%	$64.69	-42.7%
IQV Iqvia Holdings Inc	Strong Buy	30	80%	$82.96	-49.9%
MTD Mettler-Toledo International	Hold	21	43%	$170.43	-86.5%
ILMN Illumina Inc	Hold	28	54%	$169.36	+34.2%
WAT Waters Corp	Buy	28	57%	$189.60	-37.3%
WST West Pharmaceutical Services	Strong Buy	23	78%	$136.24	-44.8%